The DPP-4 Inhibitor Linagliptin Improves Cardiac Function in GLP-1 Receptor Knockout Mice with Hypertrophic Heart Failure

被引：0
|
作者：
Batchu, Sri N.
Kabir, Golam
Klein, Thomas
Connelly, Kim A.
机构：
来源：
DIABETES | 2016年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
485-P
引用
收藏
页码：A127 / A127
页数：1
相关论文
共 50 条
  • [31] The Pharmacologic Basis for Clinical Differences Among GLP-1 Receptor Agonists and DPP-4 Inhibitors
    Morales, Javier
    POSTGRADUATE MEDICINE, 2011, 123 (06) : 189 - 201
  • [32] Mortality Differences SGLT-2, DPP-4 Inhibitors and GLP-1 Receptor Agonists
    不详
    DIABETES STOFFWECHSEL UND HERZ, 2018, 27 (03): : 173 - 173
  • [33] Comparative pharmacology of the Dipeptidyl Peptidase-4 (DPP-4) metabolites of GLP-1 and the GLP-1 analogue, liraglutide
    Tomaselli, K.
    Herich, J.
    Xu, K.
    Yuskin, D.
    Collins, L.
    Crogan-Grundy, C.
    Wang, Y.
    Brunel, F.
    Lopez, J. Alfaro
    Sharma, A.
    Hanley, M.
    Ghosh, S.
    DIABETOLOGIA, 2009, 52 : S305 - S305
  • [34] Sulfonylurea Prescribing Patterns After the Introduction of DPP-4 Inhibitors and GLP-1 Receptor Agonists
    Payk, Stephanie L.
    Drew, Richard H.
    Smith, Jennifer D.
    Jiroutek, Michael R.
    Holland, Melissa A.
    CLINICAL THERAPEUTICS, 2015, 37 (07) : 1477 - 1482
  • [35] Role of GLP-1 and DPP-4 in diabetic nephropathy and cardiovascular disease
    Panchapakesan, Usha
    Mather, Amanda
    Pollock, Carol
    CLINICAL SCIENCE, 2013, 124 (1-2) : 17 - 26
  • [36] Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice
    Rieg, Timo
    Gerasimova, Maria
    Murray, Fiona
    Masuda, Takahiro
    Tang, Tong
    Rose, Michael
    Drucker, Daniel J.
    Vallon, Volker
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2012, 303 (07) : F963 - F971
  • [37] DPP-4-Hemmer und GLP-1-Rezeptor-AgonistenKardiovaskuläre Effekte DPP-4 inhibitors and GLP-1 receptor agonistsCardiovascular effects
    M. A. Nauck
    M. S. Abd El Aziz
    J. J. Meier
    Der Diabetologe, 2016, 12 : 184 - 194
  • [38] Blocking GLP-1 action with exendin [9-39] to determine the contribution of GLP-1 to the insulinotropic effects of the DPP-4 inhibitor vildagliptin
    Nauck, M. A.
    Kind, J.
    Deacon, C. F.
    Holst, J. J.
    He, Y.
    Broschag, M.
    Vardarli, I.
    Kjems, L.
    Foley, J.
    DIABETOLOGIA, 2011, 54 : S108 - S108
  • [39] Incretin-related drugs and cardiovascular events: A comparison of GLP-1 analogue and DPP-4 inhibitor
    Higashi, Yukihito
    JOURNAL OF CARDIOLOGY, 2017, 69 (3-4) : 508 - 510
  • [40] The role of GLP-1 in type 2 diabetes (T2D): effects of DPP-4 inhibition and GLP-1 receptor blockade
    Aulinger, B. A.
    de Heer, J.
    Bedorf, A.
    Kutscherauer, G.
    Goeke, B.
    Schirra, J.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2014, 122 (03)
12345